FH
Fields Heidi
Director
BoardF
Insider track record
Board DirectorNot enough buy signals with a settled T+90 horizon to measure a track record yet.
Browse the full record of transactions filed by Fields Heidi, Director. Director active across 4 companies, notably Icosavax, Inc.. In total, 14 filings have been published. Split: 0 buy · 2 sells. Total volume traded: €770k. History available since 30 July 2021. The latest transaction was disclosed on 19 May 2026 (Attribution). Regulator: SEC (Form 4). The full history is free.
Companies and markets linked to Fields Heidi
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations14 total
24,122 shares0Common StockSEC:0001193125-26-234567:0
10,500 shares0Common StockSEC:0000950170-25-082453:0
1,819 shares@ US$121.1812.4% of flowCommon StockSEC:0001127602-25-009722:0
10,500 shares0Common StockSEC:0000950170-24-064826:0
1,678 shares@ US$147.4813.9% of flowCommon StockSEC:0001127602-24-010684:0
1,658 shares@ US$144.3413.5% of flowCommon StockSEC:0001127602-24-008947:0
11,376 sharesCommon StockSEC:0000950170-24-017415:0
9,000 shares0Common StockSEC:0001209191-23-033013:0
1,658 shares@ US$136.8213.1% of flowCommon StockSEC:0000899243-23-009213:0
3,635 shares@ US$155.84133.6% of flowCommon StockSEC:0001127602-22-026417:0
5,543 shares0Common StockSEC:0001209191-22-036740:0
1,785 shares@ US$136.8213.5% of flowCommon StockSEC:0001127602-22-010051:0
8,750 shares@ US$15.00100.0% of flowCommon StockSEC:0000899243-21-031146:0
4,274 sharesCommon StockSEC:0001209191-16-089556:0
About Fields Heidi
FIELDS HEIDI is Administrateur and is associated with Agilent Technologies, INC., Phathom Pharmaceuticals, Inc., Icosavax, Inc. and Halyard Health, Inc. She has 14 filings, and, based on the most recent filings available, the sell amount is EUR 769854 over the period from 2016-01-06 to 2026-05-21, with the transaction nature shown as Attribution.